Sei Investments CO Tricida, Inc. Transaction History

Sei Investments CO

  • $74.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$4.37 - $9.46 $71,204 - $154,141
-16,294 Closed
0 $0
Q3 2020

Nov 06, 2020
SELL
$8.56 - $26.93 $7,618 - $23,967
-890 Reduced 5.18%
16,294 $148,000
Q2 2020

Aug 17, 2020
BUY
$21.21 - $31.55 $364,472 - $542,155
17,184 New
17,184 $472,000
Q3 2019

Nov 12, 2019
SELL
$29.87 - $42.22 $349,299 - $493,720
-11,694 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$31.16 - $39.46 $364,385 - $461,445
11,694 New
11,694 $461,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email